Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31601 - 31625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	EIF3A	8661	downregulated	Cisplatin results in decreased expression of EIF3A mRNA	10q26.11	A22205
Cisplatin	Approved Investigational	EIF3C	8663	downregulated	Cisplatin results in decreased expression of EIF3C mRNA	16p11.2	A20427
Cisplatin	Approved Investigational	EIF4G2	1982	upregulated	Cisplatin results in increased expression of EIF4G2 mRNA	11p15.4	A22205
Cisplatin	Approved Investigational	EIF4G3	8672	downregulated	Cisplatin results in decreased expression of EIF4G3 mRNA	1p36.12	A22204
Cisplatin	Approved Investigational	ELK4	2005	downregulated	Cisplatin results in decreased expression of ELK4 mRNA	1q32.1	A20427
Cisplatin	Approved Investigational	ELOVL6	79071	downregulated	Cisplatin results in decreased expression of ELOVL6 mRNA	4q25	A22204
Cisplatin	Approved Investigational	EMP3	2014	upregulated	Cisplatin results in increased expression of EMP3 mRNA	19q13.33	A22236
Cisplatin	Approved Investigational	ENO2	2026	upregulated	Cisplatin results in increased expression of ENO2 mRNA	12p13.31	A20427
Cisplatin	Approved Investigational	ENOSF1	55556	downregulated	Cisplatin results in decreased expression of ENOSF1 mRNA	18p11.32	A20427
Cisplatin	Approved Investigational	EP400	57634	downregulated	Cisplatin results in decreased expression of EP400 mRNA	12q24.33	A20427
Cisplatin	Approved Investigational	EPHB2	2048	downregulated	Cisplatin results in decreased expression of EPHB2 mRNA	1p36.12	A22204
Cisplatin	Approved Investigational	EPRS	2058	downregulated	Cisplatin results in decreased expression of EPRS mRNA	1q41	A20427
Cisplatin	Approved Investigational	ERCC1	2067	upregulated	Cisplatin results in increased expression of ERCC1 mRNA	19q13.32	A22231 A22247 A22248
Cisplatin	Approved Investigational	ERCC4	2072	upregulated	Cisplatin results in increased expression of ERCC4 mRNA	16p13.12	A22248
Cisplatin	Approved Investigational	ERFE	151176	upregulated	Cisplatin results in increased expression of ERFE mRNA	2q37.3	A22204
Cisplatin	Approved Investigational	ERRFI1	54206	downregulated	Cisplatin results in decreased expression of ERRFI1 mRNA	1p36.23	A22204
Cisplatin	Approved Investigational	ESR2	2100	downregulated	Cisplatin results in decreased expression of ESR2 mRNA	14q23.2-q23.3	A22218
Cisplatin	Approved Investigational	ETS2	2114	upregulated	Cisplatin results in increased expression of ETS2 mRNA	21q22.2	A22211
Cisplatin	Approved Investigational	ETV4	2118	upregulated	Cisplatin results in increased expression of ETV4 mRNA	17q21.31	A22213
Cisplatin	Approved Investigational	ETV6	2120	downregulated	Cisplatin results in decreased expression of ETV6 mRNA	12p13.2	A22204
Cisplatin	Approved Investigational	EXOC6	54536	downregulated	Cisplatin results in decreased expression of EXOC6 mRNA	10q23.33	A22204
Cisplatin	Approved Investigational	EXOC7	23265	upregulated	Cisplatin results in increased expression of EXOC7 mRNA	17q25.1	A20427
Cisplatin	Approved Investigational	EXT1	2131	downregulated	Cisplatin results in decreased expression of EXT1 mRNA	8q24.11	A22204
Cisplatin	Approved Investigational	FABP1	2168	upregulated	Cisplatin results in increased expression of FABP1 mRNA	2p11.2	A21413
Cisplatin	Approved Investigational	FAF1	11124	downregulated	Cisplatin results in decreased expression of FAF1 mRNA	1p32.3	A22204

Displaying entries 31601 - 31625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability